Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer-Reference-Cited by-同舟云学术

Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer

Published:2017-09-21 Issue:10 Volume:117 Page:1478-1485
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Sclafani Francesco,Brown Gina,Cunningham David,Wotherspoon Andrew,Mendes Larissa Sena Teixeira,Balyasnikova Svetlana,Evans Jessica,Peckitt Clare,Begum Ruwaida,Tait Diana,Tabernero Josep,Glimelius Bengt,Roselló Susana,Thomas Janet,Oates Jacqui,Chau Ian

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2017320.pdf

Reference41 articles.

1. Magnetic Resonance Tumour Regression Grade as Biomarker for Stratified Management of Rectal Cancer Patients (TRIGGER). Available at https://clinicaltrials.gov/ct2/show/NCT02704520 .

2. Beets-Tan RG, Beets GL (2004) Rectal cancer: review with emphasis on MR imaging. Radiology 232 (2): 335–346.

3. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357 (9255): 497–504.

4. Bhoday J, Smith F, Siddiqui MR, Balyasnikova S, Swift RI, Perez R, Habr-Gama A, Brown G (2016) Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy. Dis Colon Rectum 59 (10): 925–933.

5. Braendengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, Påhlman L, Wiig JN, Byström P, Bujko K, Glimelius B (2008) Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26 (22): 3687–3694.

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer;Cancers;2024-09-09

2. Papel de la resonancia magnética en la evaluación del cáncer de recto tras terapia neoadyuvante;Radiología;2024-09

3. MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer;Radiology;2024-09-01

4. Organ Preservation in Rectal Cancer: MRI and the Watch-and-Wait Approach;Radiology;2024-09-01

5. Rectal adenocarcinoma: Ex vivo 9.4T MRI—correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy;Cancer Medicine;2024-08